American BioMed gets Investigational Device Exemption (IDE) for atherectomy trial:
This article was originally published in Clinica
Executive Summary
American BioMed has received FDA permission for clinical trials of its atherectomy catheter, OmniCath. The US trial will investigate atherectomy in peripheral arteriovenous grafts. Its performance will be compared with balloon angioplasty.